ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers

MJ Henzlova, WL Duvall, AJ Einstein, MI Travin… - Journal of Nuclear …, 2016 - Springer
LEHR Low energy high resolution LVEF Left ventricular ejection fraction MBq
Megabecquerels mCi Millicuries MPI Myocardial perfusion imaging MRI Magnetic …

Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies

V Dilsizian, H Gewirtz, N Paivanas, AN Kitsiou… - Journal of Nuclear …, 2015 - Springer
Cardiovascular stress testing provides a highly effective resource for diagnosis, prognosis,
and assessment of therapeutic effectiveness and residual risk in the management of …

[HTML][HTML] Regadenoson stress testing: a comprehensive review with a focused update

KO Elkholy, O Hegazy, A Okunade, S Aktas, T Ajibawo - Cureus, 2021 - ncbi.nlm.nih.gov
Regadenoson is a pharmacological stress agent that has been widely used since its
approval by the Food and Drug Administration (FDA) in 2008. For many years, dipyridamole …

The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease

R Doukky, I Fughhi, T Campagnoli, M Wassouf… - Journal of Nuclear …, 2017 - Elsevier
Background The prognostic value of regadenoson SPECT myocardial perfusion imaging
(MPI) has not been specifically studied in patients with end-stage renal disease (ESRD) …

The significance of automatically measured transient ischemic dilation in identifying severe and extensive coronary artery disease in regadenoson, single-isotope …

Y Golzar, A Olusanya, N Pe, SG Dua, J Golzar… - Journal of Nuclear …, 2015 - Springer
Background The critical threshold and clinical significance of transient ischemic dilation
(TID) for regadenoson, single-isotope 99m Tc SPECT myocardial perfusion imaging (MPI) …

Cardiac imaging for the assessment of patients being evaluated for kidney transplantation

K Kassab, R Doukky - Journal of Nuclear Cardiology, 2022 - Elsevier
Cardiac risk assessment before kidney transplantation has become widely accepted.
However, the optimal patient selection and screening tool for cardiac assessment remain …

Safety and tolerability of regadenoson in comparison with adenosine stress cardiovascular magnetic resonance: Data from a multicentre prospective registry

JV Monmeneu Menadas, MP García Gonzalez… - … International Journal of …, 2022 - Springer
To assess the feasibility and incidence of immediate complications of stress cardiovascular
magnetic resonance (CMR) with regadenoson in comparison with adenosine in a large …

Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge

Y Golzar, R Doukky - International journal of chronic obstructive …, 2014 - Taylor & Francis
Stress testing is challenging in patients with chronic obstructive pulmonary disease (COPD).
Functional capacity is generally decreased in this patient population, limiting patients' ability …

Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease

W AlJaroudi, T Campagnoli, I Fughhi… - Journal of Nuclear …, 2016 - Elsevier
Background Blunted heart rate response (HRR) to vasodilator stress agents is associated
with worse outcomes. There are limited data assessing the effect of impaired HRR to …

Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation

K Parikh, A Appis, R Doukky - Journal of Nuclear Cardiology, 2015 - Elsevier
Cardiac risk assessment prior to kidney and liver transplantation is controversial. Given the
paucity of available organs, selecting appropriate recipients with favorable short-and long …